$7.48

+3.82 (+104.37%)

Weekly Expected Move ±76.6%

$-4 $2 $7 $13 $19

AMEX · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 65 · $377.4M mcap · 23M float · 21.76% daily turnover · Short 54% of daily vol

View Full Cash Flow Statement

No data available

Line Item	FY2025 Q4	FY2026 Q1	FY2026 Q2
— Operating Activities —
Net Income	-$27M	$552M	-$41M
Depreciation & Amort.	$13K	$0	$0
Stock-Based Comp.	$0	$0	$0
Change in Working Capital	-$543K	$2M	-$4M
Other Non-Cash Items	$25M	-$560M	$42M
Operating Cash Flow	-$2M	-$2M	-$6M
— Investing Activities —
Capital Expenditures	$0	-$77M	-$8M
Acquisitions (Net)	$0	$0	$0
Investment Purchases	$0	$0	$0
Investment Sales	$0	$0	$0
Other Investing	$0	$51M	$0
Investing Cash Flow	$0	-$26M	-$8M
— Financing Activities —
Net Debt Issuance	-$4M	$0	$0
Stock Repurchased	-$187K	-$350K	$0
Dividends Paid	-$2K	$0	$0
Other Financing	$2K	$0	$0
Financing Cash Flow	$8M	$38M	$2M

Net Change in Cash	$6M	$16M	-$11M
Cash End of Period	$8M	$18M	$7M
Free Cash Flow	-$2M	-$2M	-$6M

SDEV AMEX